Clinical Trials | May 14, 2026
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies
Subscribe To Our Newsletter & Stay Updated
